Recent News
MultiHance MRI Lawsuit Filed Over Alleged Gadolinium Side Effects
A man from California has gone to court in an effort to obtain compensation for gadolinium side effects he claims were caused by Multihance, an MRI contrast dye marketed by Bracco Diagnostics. Plaintiff: Bracco Diagnostics Failed to Adequately Warn of … Continue reading
Hernia Mesh Lawsuit News: Discovery Deadlines Extended in Ethicon Physiomesh MDL
The federal court overseeing hernia mesh lawsuits involving Ethicon, Inc.’s Physiomesh products has extended discovery deadlines for the multidistrict litigation’s potential bellwether trial cases by 75 days. Extension Delays Physiomesh Bellwether Trials The extension was announced in an Order issued … Continue reading
California Viberzi Lawsuit Claims Allergan Failed to Warn on Pancreatitis
A Viberzi lawsuit has been filed in California by a woman who was diagnosed with acute pancreatitis after initiating treatment with the Allergan IBS drug. Plaintiff Developed Pancreatitis After First Viberzi Dose According to a complaint filed in the U.S. … Continue reading
Two Risperdal Lawsuits Set for Punitive Damage Trial in Pennsylvania
A Pennsylvania court has selected two Risperdal lawsuits for trials that will determine whether or not the plaintiffs are entitled to punitive damages. Both cases were filed on behalf of men who took Risperdal as adolescents and developed gynecomastia, a … Continue reading
Louisiana Official Claims Monsanto’s Roundup Weed Killer Contributed to Lymphoma, Files Lawsuit
A member of the Jefferson Parish Council in Louisiana has filed a new Roundup lawsuit that blames his lymphoma diagnosis, at least in part, on years of exposure to Monsanto’s glyphosate-based weed killers. Monsanto Roundup Lawsuit Allegations According to a … Continue reading
Valsartan Recall Lawsuits Mount, With Class Action Filing in Missouri Federal Court
Generic drug makers are facing a growing number of valsartan lawsuits, following recalls for heart and blood pressure medications that were manufactured with a contaminated active ingredient. The complaint, which was filed in the U.S. District Court, Eastern District of … Continue reading
Chronic Kidney Disease Patients Appear to Use Proton Pump Inhibitors Longer
New research has found that patients with chronic kidney disease are prescribed proton pump inhibitors longer than average, even though the popular heart burn drugs could actually exacerbate their condition. Study Authors: Doctors Should Be Cautious in Prescribing Proton Pump … Continue reading
Testimony Concludes in California’s Latest Talcum Powder Mesothelioma Trial
Testimony has concluded in California’s latest trial involving the alleged link between Johnson & Johnson’s talcum powders and mesothelioma. Jury Urged to Award $29 Million to Life-Long Baby Powder User According to a talcum powder lawsuit filed in Los Angeles … Continue reading
FDA Warns of 2nd Cancer-Causing Chemical in Recalled Valsartan
A new cancer-causing chemical has been detected in some lots of valsartan, a generic heart and blood pressure drug that is already at the center of a massive recall. NDEA Detected in Torrent Pharmaceutical’s Recalled Valsartan Tablets According to a … Continue reading
Onglyza Lawsuit News: Bernstein Liebhard LLP Partner, Daniel C. Burke, Appointed to Plaintiffs’ Executive Committee in Federal Heart Failure Litigation
Daniel C. Burke, a partner at the nationwide law firm of Bernstein Liebhard LLP, has been appointed to the Plaintiffs’ Executive Committee in the multidistrict litigation established for all federally-filed Onglyza heart failure lawsuits. Mr. Burke’s appointment was announced in … Continue reading
Follow Us
